Burrage Capital Management as of Dec. 31, 2019
Portfolio Holdings for Burrage Capital Management
Burrage Capital Management holds 29 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Epizyme | 15.9 | $24M | 966k | 24.60 | |
| Iveric Bio | 9.5 | $14M | 1.7M | 8.58 | |
| ArQule | 8.0 | $12M | 595k | 19.96 | |
| G1 Therapeutics (GTHX) | 7.3 | $11M | 414k | 26.43 | |
| Ptc Therapeutics I (PTCT) | 6.3 | $9.4M | 196k | 48.03 | |
| Orthopediatrics Corp. (KIDS) | 5.8 | $8.7M | 186k | 46.99 | |
| Mei Pharma | 5.2 | $7.8M | 3.1M | 2.48 | |
| Ascendis Pharma A S (ASND) | 4.1 | $6.1M | 44k | 139.12 | |
| Anaptysbio Inc Common (ANAB) | 3.9 | $5.9M | 360k | 16.25 | |
| Y Mabs Therapeutics (YMAB) | 3.9 | $5.8M | 187k | 31.25 | |
| NeoGenomics (NEO) | 3.9 | $5.8M | 198k | 29.25 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.5 | $5.2M | 206k | 25.09 | |
| Cara Therapeutics (CARA) | 3.1 | $4.6M | 284k | 16.11 | |
| Aerie Pharmaceuticals | 3.0 | $4.5M | 188k | 24.17 | |
| Cytomx Therapeutics (CTMX) | 2.6 | $4.0M | 476k | 8.31 | |
| Deciphera Pharmaceuticals (DCPH) | 2.5 | $3.7M | 60k | 62.24 | |
| Tricida | 1.8 | $2.7M | 71k | 37.73 | |
| Aurinia Pharmaceuticals (AUPH) | 1.7 | $2.6M | 127k | 20.26 | |
| U.S. Physical Therapy (USPH) | 1.6 | $2.5M | 22k | 114.37 | |
| Dicerna Pharmaceuticals | 1.5 | $2.3M | 104k | 22.03 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $2.3M | 75k | 30.61 | |
| Abiomed | 1.2 | $1.7M | 10k | 170.55 | |
| Frequency Therapeutics | 0.6 | $938k | 54k | 17.53 | |
| Wave Life Sciences (WVE) | 0.6 | $849k | 106k | 8.01 | |
| Adverum Biotechnologies | 0.2 | $366k | 32k | 11.51 | |
| Solid Biosciences | 0.2 | $358k | 81k | 4.45 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $186k | 548k | 0.34 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.1 | $173k | 13k | 13.19 | |
| Aduro Biotech | 0.1 | $160k | 136k | 1.18 |
